CRSP Today - Jul 15: Six Red Days in a Row

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

CRSP Today - Jul 15: Six Red Days in a Row

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey here. I’ve been investing for a while now, and I’m breaking down the day for you. So, let’s talk about CRISPR Therapeutics, or CRSP for short. Today, it was a bit of a mixed bag, but overall, it was a red day—up just a little, but still down big over the past week.

So, here’s what went down. CRSP barely moved today, just a small uptick of around three-quarters of a percent. But man, it’s been rough lately. This stock has been on a six-day losing streak. Yeah, you heard that right—six days! It’s dropped about 18% during that time. That’s gotta hurt. People are feeling pretty jittery about it.

Now, what’s behind this downward trend? Well, it seems like a combo of things. There’s been a lot of chatter about the overall market and how it’s affecting biotech stocks, especially gene-editing companies like CRISPR. Investors are getting a bit cautious, and when that happens, they tend to hit the sell button fast. Plus, there hasn’t been any major news or breakthroughs from CRISPR lately to boost confidence. So, folks are left wondering what’s next.

On a slightly brighter note, there’s been some movement in the background. Canal Insurance just bought a new stake in CRISPR. While it’s not a game-changer, it does show that some investors see potential here, even if the stock’s been struggling. It’s like a glimmer of hope amidst the storm.

Overall, it’s been a tough time for CRISPR, but that’s how the market rolls sometimes. Just remember, investing can be a wild ride. Keep your head up, and don’t let the ups and downs get you down. This is all for fun and info, not financial advice. Catch you later!

まだレビューはありません